Web Results

J&J Wins U.S. Approval for First-in-Class Diabetes Drug - Bloomberg


Mar 29, 2013 ... J&J Wins Approval for First in New Class of Diabetes Drugs. Johnson ... “I worry its use in women will be somewhat minimal,” Butler said.

UPDATED: J&J wins first FDA approval for new class of diabetes drug


Mar 29, 2013 ... The approval gives the healthcare giant its first market green light for a new ... UPDATED: J&J wins first FDA approval for new class of diabetes drug ... with a relatively high rate of genital infections which will limit uptake in our ...

J&J faces big spending, big rivals for new diabetes drug Invokana ...


Apr 1, 2013 ... And J&J ($JNJ) will have to spend a pretty penny on detailing and advertising to ... And it's true that diabetes patients often have to change meds to keep control of ... J&J wins first FDA approval for new class of diabetes drug

FDA Approves First in New Class of Diabetes Drugs - Invokana


Apr 5, 2013 ... The FDA has approved Invokana (canagliflozin), the first drug in a new class of ... As the first company to win FDA approval, Johnson & Johnson has a leg up on industry rivals developing their own ... More details on the studies will be presented at the American Diabetes Association annual meeting in June.

FDA Approves Johnson Johnsons New Diabetes Drug - BioSpace


Apr 1, 2013 ... "Patients with type 2 diabetes struggle managing their blood sugar, and nearly half of ... Janssen will partner with other Johnson & Johnson companies focused on ..... (BIIB) Wins FDA Approval for Blockbuster Oral MS Drug.

Johnson & Johnson, Viacyte testing possible diabetes cure | Fox News


Feb 4, 2016 ... Johnson & Johnson, continuing its long quest for a Type 1 diabetes cure, ... "We wanted to hedge our bets to make sure we would win in this space ... Further testing may be needed before the product can be approved by regulators. .... Does anyone for a second think that ANY socialized medicine nation or ...

Samsung Has Johnson & Johnson's Best-Selling Drug in Its ...


May 24, 2016 ... Samsung Has a Best-Selling American Drug in Its Crosshairs ... It's chasing U.S. approval for a biosimilar of Remicade. ... And on Monday, the company said the FDA will review the application for its biosimilar of Johnson & Johnson's ... the Remicade biosimilar in America if it wins the FDA's blessing.

FDA Approves J&J's New Diabetes Drug - WSJ


Mar 29, 2013 ... Some analysts think doctors will use the SGLT class as a last-line option ... The FDA's approval of Invokana is a milestone for J&J because, although the ... meters, Invokana is its first prescription drug for type 2 diabetes.

Drug Sales Are Driving Johnson & Johnson's Growth - Fortune


Jan 26, 2016 ... GM's $421 Million Investment Deal Wins Approval By Canadian Union ... Healthcare conglomerate Johnson & Johnson has its growing drug sales to ... vision care, and diabetes care, part of the same division, won't be affected by the cuts. ... The diversified growth will be especially important as Johnson ....

FDA OKs Janssen's Ivokana for Diabetes | Medpage Today


The drug is the only compound approved for diabetes that does not have an ... drugmaker Janssen Pharmaceuticals, a Johnson & Johnson company, will ... and is contraindicated in patients who have increased ketones in their blood or urine.

More Info

Johnson & Johnson's New Diabetes Drug: A Blockbuster in the ...


Apr 21, 2014 ... Johnson's Invokana is about to face a host of new SGLT2 competitors ... Since Invokana helped lift Johnson's first-quarter sales in the U.S. last quarter, let's look at its ... Express Scripts expects spending on diabetes treatment will grow 11% in ... the first in a new class of diabetes drugs to win FDA ap...

UPDATE 1-J&J says its diabetes drug should have same survival ...


Oct 13, 2015 ... UPDATE 1-J&J says its diabetes drug should have same survival edge ... diabetes drug to save lives in a large clinical trial is a benefit that will likely ... UPDATE 1-Wabtec to win EU approval for $1.8 bln Faiveley deal -sources.

Invokana Wins F.D.A. Approval for Diabetes Treatment - The New ...


Mar 30, 2013 ... The drug, Invokana, will be sold by Johnson & Johnson and treats patients with type 2 diabetes in a new way, by causing blood sugar to be ...